Growth hormone, gender and face shape in prader-willi syndrome

American Journal of Medical Genetics, Part A

Volumn 161, Issue 10, 2013, Pages 2453-2463

  de Souza, Mauren Abreu ^a   Mcallister, Catherine ^b   Suttie, Michael ^a   Perrotta, Concetta ^c   Mattina, Teresa ^c   Faravelli, Francesca ^d   Forzano, Francesca ^d   Holland, Anthony ^b   Hammond, Peter ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CATANIA   (Italy)

^d Medical Genetics Unit   (Italy)

Author keywords

Dense surface modelling; Face signature; Growth hormone therapy; Prader Willi syndrome (PWS)

Indexed keywords

HUMAN GROWTH HORMONE; SEX HORMONE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CRANIOFACIAL MORPHOLOGY; DENSE SURFACE MODELLING; DEVELOPMENTAL STAGE; DIAGNOSTIC IMAGING; FACE; FACE GROWTH; FACE MALFORMATION; FACIES; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HORMONAL THERAPY; HORMONE SUBSTITUTION; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NOSE; ONSET AGE; PRADER WILLI SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SEX DIFFERENCE; SHAPE SIGNATURE TECHNIQUE; THREE DIMENSIONAL IMAGING; TREATMENT DURATION; TREATMENT OUTCOME;

PRUNUS DULCIS;

DENSE SURFACE MODELLING; FACE SIGNATURE; GROWTH HORMONE THERAPY; PRADER-WILLI SYNDROME (PWS);

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FACE; FACIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; IMAGING, THREE-DIMENSIONAL; INFANT; MALE; MIDDLE AGED; PRADER-WILLI SYNDROME; SEX FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84885022777     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36100     Document Type: Article

References (42)

1. Allanson JE, Clericuzio C, Cassidy SB. 2000. Prader-Willi syndrome: Phenotypic differences observed in an objective study of deletion and disomy. Proc Greenwood Genet Center 19:117.
2. Boehringer S, Guenther M, Sinigerova S, Wurtz RP, Horsthemke B, Wieczorek D. 2011. Automated syndrome detection in a set of clinical facial photographs. Am J Med Genet Part 155:2161-2169.
3. Butler MG, Levine GJ, Le JY, Hall BD, Cassidy SB. 1995. Photoanthropometric study of craniofacial traits of individuals with Prader-Willi syndrome. Am J Med Genet 58:38-45.
4. Butler MG, Hovis CL, Angulo M. 1998. A Photoanthropometric study of craniofacial traits in individuals with Prader-Willi syndrome on short-term growth hormone therapy. Clin Genet 53:268-275.
5. Carrel SE, Myers B, Whitman J, Allen DB. 2010. Long-Term growth hormone therapy changes the natural history of body composition and motor function in children with Prader-Willi Syndrome. J Clin Endocrinol Metab 95:1131-1136.
6. Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. 2012. Prader-Willi Syndrome. Genet Med 14:10-26.
7. Cassidy SB, Simpson E, Heeger S. 2004. Facial phenotype of Prader-Willi syndrome becomes more normal with early growth hormone treatment. http://www.pwsausa.org/Scnceday/2004/facial_phenotype_of_praderwilli.htm .
8. Cassidy SB, Driscoll DJ. 2009. Prader-Willi syndrome. Eur J Hum Genet 17:3-13.
9. Cassidy SB, Forsythe M, Heeger S, Nicholls RD, Schork N, Benn P, Schwartz S. 1997. Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet 68:433-440.
10. Chinthapalli K, Bartolin Ei, Novy J, Suttie M, Marini C, Falchi M, Fox Z, Clayton LMS, Sander JW, Guerrini R, Depondt C, Hennekam R, Hammond P, Sisodiya SMS. 2012. Atypical face shape and genomic structural variants in epilepsy. Brain 135:3101-3114.
11. Claes P, Daniels K, Walters M, Clement J, Vandermeulen D, Suetens P. 2012. Dysmorphometrics: The modelling of morphological abnormalities. Theor Biol Med Model 9:5.
12. Ellson J, Gansber E, Koutsofios L, North S, Woodhull GGraphviz. 2002. Open source graph drawing tools. Lect Notes Comput Sci 2265/2002:594-597.
13. Goldstone AP. 2004. Prader-Willi syndrome: Advances in genetics, pathophysiology and treatment. Trends Endocrinol Metab 15:12-21.
14. Gwilliam JR, Cunningham SJ, Hutton TJ. 2006. Reproducibility of soft tissue landmarks on three-dimensional facial scans. Eur J Orthod 28:08-15.
15. Haig D, Wharton R. 2003. Prader-Willi syndrome and the evolution of human childhood. Am J Hum Biol 15:320-329.
16. Hammond P. 2007. The use of 3D face shape modelling in dysmorphology. Arch Dis Child 92:1120-1126.
17. Hammond P, Hutton TJ, Allanson JE, Campbell LE, Hennekam RC, Holden S, Patton MA, Shaw A, Temple IK, Trotter M, Murphy KC, Winter RM. 2004. 3D analysis of facial morphology. Am J Med Genet 126:339-348.
18. Hammond P, Hutton TJ, Allanson JE, Buxton B, Campbell L, Clayton-Smith J, Donnai D, Karmiloff-Smith A, Metcalfe K, Murphy KC, Patton M, Pober B, Prescott K, Scambler P, Shaw A, Smith AC, Stevens AF, Temple IK, Hennekam R, Tassabehji M. 2005. Discriminating power of localized 3D facial morphology. Am J Hum Genet 77:999-1010.
19. Hammond P, Suttie M. 2012. Large scale objective phenotyping of facial morphology in 3D. Hum Mutat 33:817-825.
20. Hammond P, Suttie M, Hennekam RC, Allanson J, Shore EM, Kaplan FS. 2012. The facial signature of Fibrodysplasia Ossificans Progressiva. Am J Med Genet A 158A:1368-1380.
21. Hammond P, Hannes F, Suttie M, Devriendt K, Vermeesch JR, Faravelli F, Forzano F, Parekh S, Williams S, McMullan D, South ST, Carey J, Quarrell O. 2012. Fine grained facial phenotype-genotype analysis in Wolf-Hirschhorn syndrome. Eur J Hum Genet 20:33-40.
22. Hammond P, Forster-Gibson C, Chudley AE, Allanson JE, Hutton TJ, Holden JJA, Lewis MES. 2008. Face-brain asymmetry in autism spectrum disorders. Mol Psych 13:614-623.
23. Hass AD, Simmons KE, Davenport ML, Proffit WR. 2001. The effect of growth hormone on craniofacial growth and dental maturation in Turner syndrome. Angle Orthod 7:50-59.
24. Heulens I, Suttie M, Postnov A, De Clerck N3, Perrotta CS, Mattina T, Faravelli F, Forzano F, Kooy RF, Hammond P. 2012. Craniofacial characteristics of fragile X syndrome in mouse and man. Eur J Hum Genet doi: 10.1038/ejhg.2012.265 [Epub ahead of print].
25. Holland AJ, Whittington JE, Butler J, Webb T, Boer H, Clarke DJ. 2003. Behavioural phenotypes associated with specific genetic disorders: Evidence from a population-based study of people with Prader-Willi Syndrome. Psych Med 33:141-153.
26. Honea RA, Holsen LM, Lepping RJ, Perea R, Butler MG, Brooks WM, Savage CR. 2012. The neuroanatomy of genetic subtype in Prader-Willi syndrome. Am J Med Gen Part B 159B:243-253.
27. Hutton TJ, Buxton BF, Hammond P. 2003. Estimating average growth trajectories in shape-space using kernel smoothing. IEEE Trans Med Imaging 22:747-753.
28. Job JC. 1990. Results of long-term growth hormone replacement therapy in children: When and how to treat? Horm Res 33:69-76.
29. Juloski J, Glisic B, Scepan I, Milasin J, Mitrovic K, Babic M. 2013. Ontogenetic changes of craniofacial complex in Turner syndrome patients treated with growth hormone. Clin Oral Invest 17:1563-1571.
30. Kasperavičiute D, Catarino CB, Chinthapalli K, Clayton LMS, Thom M, Martinian L, Cohen H, Adalat S, Bockenhauer D, Pope S, Lench N, Koltzenburg N, Duncan JS, Hammond P, Hennekam RCM, Land JM, Sisodiya S. 2011. Uncovering genomic causes of co-morbidity in epilepsy: Gene-driven phenotypic characterization of rare micro-deletions. PLoS ONE 6:e23182.
31. Kim SJ, Miller JL, Kuipers PJ, German JR, Beaudet AL, Sahoo T, Driscoll DJ. 2011. Unique and atypical deletions in Prader-Willi syndrome reveal distinct phenotypes. Eur J Hum Genet 20:283-290.
32. Lipinski RJ, Hammond P, O'Leary-Moore SK, Ament JJ, Pecevich SJ, Jiang Y, Budin F, Parnell SE, Suttie M, Godin EA, Everson JL, Dehart DB, Oguz I, Holloway HT, Styner M, Johnson GA, Sulik KK. 2012. Stage-specific ethanol exposure causes unique face-brain dysmorphology patterns in a mouse model of fetal alcohol spectrum disorder. PLoS ONE 7.
33. Meaney FJ, Butler MG. 1987. Craniofacial variation and growth in the Prader-Labhart-Willi syndrome. Am J Phys Anthropol 74:459-464.
34. Milner RD, Russell-Fraser T, Brook CG, Cotes PM, Farquhar JW, Parkin JM, Preece MA, Snodgrass GJ, Mason AS, Tanner JM, Vince FP. 1979. Experience with human growth hormone in Great Britain: The report of the MRC Working Party. Clin Endocrinol (Oxf) 11:15-38.
35. Novy J, Catarino CB, Chinthapalli K, Smith SM, Clayton-Smith J, Hennekam RC, Hammond P, Sisodiya SM. 2012. Another cause of vaccine encephalopathy: a case of Angelman syndrome. Eur J Med Genet, 55:338-341.
36. Schaedel R, Poole AE, Cassidy SB. 1990. Cephalometric analysis of the Prader-Willi syndrome. Am J Med Gen 36:484-487.
37. Suttie M, Foroud T, Wetherill L, Jacobson S, Jacobson JL, Molteno CD, Hoyme HE, Riley E, Hammond P. 2012. Facial dysmorphism across the fetal alcohol spectrum. Pediatrics 131:e779-e788.
38. Tassabehji M, Hammond P, Karmiloff-Smith A, Metcalfe K, Thompson P, Durkin M, Popescu NC, Hutton T, Metcalfe K, Rucka A, Stewart H, Read AP, Maconochie M, Donnai D. 2005. GTF2IRD1 in craniofacial development of humans and mice. Science 310:1184-1187.
39. Tobin JL, DiFranco M, Eichers E, May-Simera H, Garcia M, Yan J, Justice M, Briscoe J, Mayor R, Lupski JR, Hammond P, Beales PL. 2008. Defects of Shh transduction and neural crest cell migration underlie craniofacial dysmorphology in Bardet-Biedl syndrome. PNAS 105:6714-6719.
40. Whittington JE, Holland AJ, Webb T, Butler J, Clarke D, Boer H. 2001. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi Syndrome in one health district. J Med Genet 38:792-798.
41. Whittington JE, Holland AJ, Webb T, Butler JV, Clarke DJ, Boer H. 2001. Relationship between clinical and genetic diagnosis of Prader-Willi Syndrome. J Med Genet 39:926-932.
42. Whittington JE, Holland AJ, Webb T, Butler JV, Clarke DJ, Boer H. 2004. Cognitive abilities and genotype in a population-based sample of people with Prader-Willi syndrome. JIDR 48:172-187.